Healthcare-Associated Pneumonia: Clinical Trials

48 trials for Healthcare-Associated Pneumonia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

23 completed, 11 unknown, 9 terminated, 2 not yet recruiting. 48 Phase 2, 13 Phase 3, 5 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 248Completed 23, Unknown 11, Terminated 9, Not yet recruiting 2, Withdrawn 2, Recruiting 1
Phase 313Unknown 6, Completed 2, Terminated 2, Withdrawn 2, Not yet recruiting 1
Phase 15Completed 3, Unknown 2

Follow Healthcare-Associated Pneumonia: new trials by email Literature Review of Healthcare-Associated Pneumonia trials Research Report on Healthcare-Associated Pneumonia

Trials (filtered) newest first · largest first

All 48 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Nebulised Colistimethate Sodium to Prevent Pediatric Ventilator-associated Pneumonia
colistimethate sodium, 0.9% Saline - Ventilator Associated Pneumonia
Phase 2 / Phase 3Not yet recruitingUniversity Hospital Fattouma Bourguiba4002027-01-012026-10-08
" Study of the Benefit of Nebulized Amikacin in the Treatment of Gram-negative Bacillus Pneumonia Acquired During Mechanical Ventilation in Patients Receiving Extracorporeal Membrane Veno-arterial Oxygenation "
Amikacin, Standard of care - Pneumonia, Bacterial, Extracorporeal Membrane Oxygenation
Phase 2RecruitingAssistance Publique - Hôpitaux de Paris262026-08-102026-08-13
Microbiome-guided Prophylaxis to Reduce Ventilator-Associated Pneumonia in Intensive Care Units: A Pilot Randomized Controlled Trial
Microbiome-guided inhaled antibiotic prophylaxis, Placebo - Critical Illness, Mechanical Ventilation
Phase 2Not yet recruitingUniversity of Calgary702026-05-012026-03-11
Phase 1/2a to Assess the Safety and Tolerability of TP-122A for the Treatment of Ventilator-Associated Pneumonia
TP-122A - Pneumonia, Ventilator-Associated
Phase 1 / Phase 2UnknownTechnophage, SA152024-09-012024-04-17
"Baricitinib for Treating Hospital-acquired Pneumonia in Critically Ill Patients With a Proinflammatory Phenotype.
Baricitinib 4 MG - Hospital-acquired Pneumonia
Phase 2 / Phase 3UnknownNantes University Hospital4502023-07-012023-06-22
Oro-nasal Decontamination to Prevent Ventilator-associated Pneumonia
Povidone-Iodine, Saline spray - Ventilator Associated Pneumonia
Phase 2 / Phase 3CompletedMenoufia University782023-06-242023-11-27
PK of BV100 in Patients VABP Suspected or Confirmed to Be Due to CRAB
BV100 plus Polymyxin B, BAT - Ventilator Associated Pneumonia
Phase 2CompletedBioVersys AG392023-04-202025-01-14
Use of Presepsin as a Marker for Immunotherapy Administration in Pneumonia
Anakinra Prefilled Syringe, Placebo - Community-acquired Pneumonia, Hospital-acquired Pneumonia
Phase 2CompletedHellenic Institute for the Study of Sepsis602023-03-062024-07-31
Safety of Nebulized Combination Therapy BromAc® in COVID-19 Respiratory Disease
Bromelains, Acetylcysteine - COVID-19 Pneumonia, COVID-19
Phase 1 / Phase 2UnknownMucpharm Pty Ltd302022-05-012022-02-28
Intravenous Metoprolol in Septic Shock
Intravenous metoprolol tartrate, Standard Care (in control arm) - Septic Shock, Ventilator Acquired Pneumonia
Phase 2CompletedAlexandria University1002022-04-012025-01-29
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of Cefiderocol in Hospitalized Pediatric Participants
Cefiderocol, Standard of Care - Gram-negative Bacterial Infections, Bloodstream Infections (BSI)
Phase 2CompletedShionogi532020-08-212026-02-27
Vitamin C Infusion for the Treatment of Severe 2019-nCoV Infected Pneumonia
VC, Sterile Water for Injection - Vitamin C, Pneumonia, Viral
Phase 2TerminatedZhiYong Peng562020-02-142020-10-12
Umbilical Cord(UC)-Derived Mesenchymal Stem Cells(MSCs) Treatment for the 2019-novel Coronavirus(nCOV) Pneumonia
UC-MSCs - Pneumonia, Viral, Pneumonia, Ventilator-Associated
Phase 2UnknownZhiYong Peng162020-02-062020-07-01
Endotracheal Tubes to Prevent Ventilator-Associated Pneumonia
EVAC-PU-ETT, PVC-ETT - Ventilator-acquired Pneumonia
Phase 2CompletedYale University10742019-05-062024-09-24
Coated Devices to Decrease Infection in the Intensive Care Unit
Coated devices, Control - Critically Ill
Phase 1 / Phase 2CompletedHospital do Coracao1032019-04-062020-03-09
Nebulized Aztreonam for Prevention of Gram Negative Ventilator-associated Pneumonia
Aztreonam lysine, Aerogen Solo, CombiHaler - Ventilator Associated Pneumonia, Prevention
Phase 2 / Phase 3TerminatedHospital Universitari Joan XXIII de Tarragona.92019-03-192021-07-01
Low Versus High Corticosteroid Use in Ventilator Associated Pneumonia
methylprednisolone, Methyl Prednisolonate, ventilators - Ventilator Associated Pneumonia
Phase 2CompletedKing Abdul Aziz Specialist Hospital2402018-01-022020-07-13
Prevention of S. Aureus Pneumonia Study in Mechanically Ventilated Subjects Who Are Heavily Colonized With S. Aureus.
ASN100, Placebo - Pneumonia, Ventilator-associated, Pneumonia, Staphylococcal
Phase 2TerminatedArsanis, Inc.1552016-11-012019-07-31
The Effect of Colistin Inhalation on Ventilator Associated Pneumonia
Colistin, Carbapenem + Aminoglycoside/ Quinolone - Ventilator Associated Pneumonia
Phase 2 / Phase 3CompletedNourhan Hassan Osama Thuraya Mohamed402016-01-022018-08-09
Atropine for Preventing Ventilator-Associated Pneumonia
Atropine, Placebo - Ventilator-Associated Pneumonia
Phase 2CompletedUniversidade de Passo Fundo402015-02-012016-03-10

Showing 20 of 48. Sign in to see all of them.

Narrower conditions

Pneumonia, Ventilator-Associated (42)  ·  Pneumonia (18)  ·  Pseudomonas Infections (5)  ·  Pneumonia, Bacterial (4)  ·  Sepsis (3)  ·  Bacteremia (2)  ·  Bacterial Infections (2)  ·  COVID-19 (2)  ·  Critical Illness (2)  ·  Cross Infection (2)  ·  Infections (2)  ·  Pneumonia, Viral (2)  ·  Respiratory Tract Infections (2)  ·  Abdominal Abscess (1)

Broader conditions

Disease Attributes (48)  ·  Iatrogenic Disease (48)  ·  Lung Diseases (48)  ·  Pathologic Processes (48)  ·  Pathological Conditions, Signs and Symptoms (48)  ·  Respiratory Tract Diseases (48)  ·  Cross Infection (46)  ·  Infections (46)  ·  Respiratory Tract Infections (46)  ·  Pneumonia (30)  ·  Bacterial Infections and Mycoses (13)  ·  Bacterial Infections (11)  ·  Inflammation (6)  ·  Systemic Inflammatory Response Syndrome (6)

Interventions

Colistin (3)  ·  Doripenem (3)  ·  Saline Solution (3)  ·  Standard of Care (3)  ·  Amikacin (2)  ·  Ascorbic Acid (2)  ·  Chlorhexidine (2)  ·  Cilastatin, Imipenem Drug Combination (2)  ·  Injections (2)  ·  Polymyxin B (2)  ·  Sodium Chloride (2)  ·  Toothbrushing (2)  ·  Vancomycin (2)  ·  colistinmethanesulfonic acid (2)  ·  ASN100 (1)

Sponsors

Hospital Universitari Joan XXIII de Tarragona. (2)  ·  ZhiYong Peng (2)  ·  Alexandria University (1)  ·  Anbics Management-Services Ag (1)  ·  Arpida AG (1)  ·  Arsanis, Inc. (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Association Pour La Promotion A Tours De La Reanimation Medicale (1)  ·  BioVersys AG (1)  ·  Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (1)  ·  Daren K. Heyland (1)  ·  General Hospital of Shenyang Military Region (1)  ·  Groupe Hospitalier Pitie-Salpetriere (1)  ·  Hellenic Institute for the Study of Sepsis (1)  ·  Hospital do Coracao (1)

Countries

United States (13)  ·  France (10)  ·  Spain (7)  ·  China (6)  ·  Canada (4)  ·  Hungary (4)  ·  Russia (4)  ·  Belgium (3)  ·  Georgia (3)  ·  Greece (3)  ·  Ukraine (3)  ·  Argentina (2)  ·  Austria (2)  ·  Brazil (2)  ·  Chile (2)

Top investigators

Alexandre Biasi, MD/PhD (1)  ·  Antoni Torres, MD PhD (1)  ·  Christian Van Delden, MD (1)  ·  Cindy L Munro, RN,ANP,PHD (1)  ·  Cindy Munro, RN, ANP,PhD (1)  ·  Daren Heyland, MD (1)  ·  David Lye, MBBS, FRACP (1)  ·  David Willms, MD (1)  ·  Deborah J Cook, MD (1)  ·  Evangelos Giamarellos-Bourboulis, MD PhD (1)  ·  Evangelos Giamarellos-Bourboulis, MD, PhD (1)  ·  Frank A. Scannapieco, DMD PhD (1)  ·  Frank MP van Haren, MD, PhD (1)

Results publications

PMID 18991508, PMID 19482956, PMID 19765321, PMID 20463812, PMID 21287306, PMID 23357775, PMID 24981955, PMID 25050644, PMID 25317722, PMID 26472037, PMID 27080532, PMID 27480757, PMID 27965798, PMID 28159015, PMID 29041861, PMID 30526610, PMID 32526149, PMID 32595159, PMID 32641343, PMID 36289153, PMID 38676438, PMID 39230271, PMID 41319662, PMID 41552367, PMID 8888088

NIH funding

R01NR007652 (2), 2016 (1), 2019 (1), R01DE014685 (1), R33HL138650 (1)